NCT07516353
- Conditions
- ALL, AML, Acute Lymphoblastic Leukemia ,Lymphomas, +32 more
- Locations
-
- Dana Farber Cancer Institute Boston, Massachusetts, United States
Clinical trial condition
Leukemia, Myeloid
Explore clinical trials studying Leukemia, Myeloid. Study availability and eligibility vary by location and protocol.
3,104 public trials
618 recruiting studies
Leukemia, Myeloid trial results
Not Yet Recruiting
Phase I Clinical Trial of ThINKK Adoptive Immunotherapy After Allogeneic Hematopoietic Transplantation in Children With Leukemia or Neuroblastoma
NCT07518654
- Conditions
- Hematologic Diseases, Hematopoetic Stem Cell Transplant, Hematopoetic Stem Cell Transplantation, +32 more
- Locations
-
- The Hospital for Sick Children Toronto, Ontario, Canada
- CHU Sainte-Justine Montreal, Quebec, Canada
Not Yet Recruiting
Axatilimab Combined With Decitabine/Venetoclax for the Treatment of TP53-mutated AML
NCT07511062
- Conditions
- Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
- Locations
-
- Northside Hospital, Inc. Atlanta, Georgia, United States
Not Yet Recruiting
Exploratory Study of Venetoclax, Homoharringtonine, Azacitidine Plus G-CSF for Newly Diagnosed AML (VHAG)
NCT07507825
- Conditions
- Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
- Locations
-
- Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University Hangzhou, Zhejiang, China
Not Yet Recruiting
Efficacy and Safety of Lisafotoclax Plus Decitabine and Homoharringtonine in Venetoclax/Azacitidine Pretreated AML Patients
NCT07505160
- Conditions
- Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
- Locations
-
- The Second Affiliated Hospital, Zhejiang University School of Medicine Hangzhou, Zhejiang, China
Not Yet Recruiting
VAG Versus Standard Chemotherapy With FLT3 Inhibitor in Adult Patients With FLT3-Mutated AML
NCT07407140
- Conditions
- AML, Adult, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
- Locations
-
Not specified
Not Yet Recruiting
TGRX-678 Chinese Phase III in Chronic Myelogenous Leukemia (CML) Patients
NCT07489755
- Conditions
- Bone Marrow Diseases, Chronic Disease, Chronic Myelogenous Leukemia, +13 more
- Locations
-
Not specified
Not Yet Recruiting
Clonal Hematopoiesis of Immunological Significance
NCT05969821
- Conditions
- Autoimmune Diseases, Autoinflammatory Diseases, Blood Protein Disorders, +27 more
- Locations
-
- AP-HP, Service de médecine interne, Hôpital Saint Antoine Paris, France
Not Yet Recruiting
Aclarubicin Plus With Azacitidine and Venetoclax in the Treatment of Acute Myeloid Leukemia
NCT07486726
- Conditions
- Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +7 more
- Locations
-
- Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai Shanghai, China
- Shanghai Jing'an District Beizhan Hospital Shanghai, China
- Shanghai Traditional Chinese Medicine Hospital Shanghai, China
- Tongren Hospital, Shanghai Jiao Tong University School of Medicine Shanghai, China
Not Yet Recruiting
HEM-SURVIVE: Structuralized Follow-up for Childhood Hematological Malignancy Survivors
NCT07483749
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Hematologic Diseases, +14 more
- Locations
-
- Children's hospital, Zhejiang University School of Medicine Hangzhou, Zhejiang, China
- Hangzhou Children's Hospital Hangzhou, Zhejiang, China
- Affiliated Women and Children's Hospital of Ningbo University Ningbo, Zhejiang, China